{"transactions":[{"id":711804,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2026-07-09T13:05:31.000Z","date":"2026-06-30","kind":"other","planned":false,"acquired":true,"shares":1453,"price":10.914,"value":15858.042,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2025 Employee Stock Purchase Plan."}],"balance_after":2154,"source":{"system":"sec-edgar","filing":"0001493152-26-032615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000149315226032615/ownership.xml","form_type":"4"}},{"id":879644,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2026-02-26T12:03:05.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39011,"derivative":{"exercise_price":17.8625,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39011},"source":{"system":"sec-edgar","filing":"0001999371-26-004388","document":"saenger-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000199937126004388/saenger-form4_022626.xml","form_type":"4"}},{"id":879643,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2026-02-26T12:03:05.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39012,"derivative":{"exercise_price":14.29,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39012},"source":{"system":"sec-edgar","filing":"0001999371-26-004388","document":"saenger-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000199937126004388/saenger-form4_022626.xml","form_type":"4"}},{"id":901000,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2026-02-17T12:00:19.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":701,"price":13.42,"value":9407.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2025 Employee Stock Purchase Plan."}],"balance_after":701,"source":{"system":"sec-edgar","filing":"0001999371-26-003371","document":"saenger-form5_021626.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000199937126003371/saenger-form5_021626.xml","form_type":"5"}},{"id":1240707,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2025-02-27T23:51:04.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":25792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":25792,"derivative":{"exercise_price":10.0625,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":25792},"source":{"system":"sec-edgar","filing":"0001839882-25-011958","document":"saenger-form4_022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000183988225011958/saenger-form4_022725.xml","form_type":"4"}},{"id":1240706,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2025-02-27T23:51:04.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":25792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":25792,"derivative":{"exercise_price":8.05,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":25792},"source":{"system":"sec-edgar","filing":"0001839882-25-011958","document":"saenger-form4_022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000183988225011958/saenger-form4_022725.xml","form_type":"4"}},{"id":1240705,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2025-02-27T23:51:04.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":0.04,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were surrendered without considerations following a reverse stock split of the Issuer's common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-011958","document":"saenger-form4_022725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000183988225011958/saenger-form4_022725.xml","form_type":"4"}},{"id":1610026,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:07:19.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":282000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":282000,"derivative":{"exercise_price":0.46,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":282000},"source":{"system":"sec-edgar","filing":"0001999371-24-002951","document":"saenger-form4_022724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000199937124002951/saenger-form4_022724.xml","form_type":"4"}},{"id":1610025,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:07:19.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":282000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":282000,"derivative":{"exercise_price":0.368,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":282000},"source":{"system":"sec-edgar","filing":"0001999371-24-002951","document":"saenger-form4_022724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000199937124002951/saenger-form4_022724.xml","form_type":"4"}},{"id":1993235,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2023-02-24T23:37:39.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":200000,"derivative":{"exercise_price":0.914,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001839882-23-004703","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000183988223004703/ownership.xml","form_type":"4"}},{"id":1993234,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2023-02-24T23:37:39.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":200000,"derivative":{"exercise_price":0.731,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001839882-23-004703","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000183988223004703/ownership.xml","form_type":"4"}},{"id":2388530,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2022-02-17T22:19:03.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance."}],"balance_after":900000,"derivative":{"exercise_price":0.828,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001387131-22-002107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713122002107/ownership.xml","form_type":"4"}},{"id":2388529,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2022-02-17T22:19:03.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance."}],"balance_after":900000,"derivative":{"exercise_price":0.621,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001387131-22-002107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713122002107/ownership.xml","form_type":"4"}},{"id":2388528,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2022-02-17T22:19:03.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance."}],"balance_after":900000,"derivative":{"exercise_price":0.414,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001387131-22-002107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713122002107/ownership.xml","form_type":"4"}},{"id":2388527,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2022-02-17T22:19:03.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":900000,"derivative":{"exercise_price":0.207,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001387131-22-002107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713122002107/ownership.xml","form_type":"4"}},{"id":2401627,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2022-02-11T22:18:48.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":18248,"price":0.58,"value":10583.84,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2020 Employee Stock Purchase Plan."}],"balance_after":19645,"source":{"system":"sec-edgar","filing":"0001387131-22-001717","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713122001717/ownership.xml","form_type":"5"}},{"id":2832794,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2021-02-25T22:52:16.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":540000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":540000,"derivative":{"exercise_price":1.53,"exercise_date":"2022-02-23","expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":540000},"source":{"system":"sec-edgar","filing":"0001387131-21-002888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713121002888/ownership.xml","form_type":"4"}},{"id":2832793,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2021-02-25T22:52:16.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":540000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":540000,"derivative":{"exercise_price":1.22,"exercise_date":"2022-02-23","expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":540000},"source":{"system":"sec-edgar","filing":"0001387131-21-002888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713121002888/ownership.xml","form_type":"4"}},{"id":2863391,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-12T22:32:16.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":493,"price":1.02,"value":502.86,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2019 Employee Stock Purchase Plan."}],"balance_after":1397,"source":{"system":"sec-edgar","filing":"0001387131-21-002306","document":"tnxp-form5_123120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713121002306/tnxp-form5_123120.xml","form_type":"5"}},{"id":3159563,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2020-05-06T22:26:28.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":360000,"derivative":{"exercise_price":0.96,"exercise_date":"2021-05-04","expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001387131-20-004485","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713120004485/ownership.xml","form_type":"4"}},{"id":3159562,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2020-05-06T22:26:28.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":360000,"derivative":{"exercise_price":0.77,"exercise_date":"2021-05-04","expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001387131-20-004485","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713120004485/ownership.xml","form_type":"4"}},{"id":3243932,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2020-02-27T21:24:42.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":24000,"derivative":{"exercise_price":0.5,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001387131-20-002257","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713120002257/ownership.xml","form_type":"4"}},{"id":3243931,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2020-02-27T21:24:42.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":24000,"derivative":{"exercise_price":0.4,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001387131-20-002257","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713120002257/ownership.xml","form_type":"4"}},{"id":3270742,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2020-02-14T21:14:38.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":815,"price":11.82,"value":9633.3,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2019 Employee Stock Purchase Plan."}],"balance_after":904,"source":{"system":"sec-edgar","filing":"0001387131-20-001792","document":"saenger-form5_123119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713120001792/saenger-form5_123119.xml","form_type":"5"}},{"id":3270741,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2020-02-14T21:14:38.000Z","date":"2019-02-17","kind":"grant","acquired":true,"shares":59,"price":17.85,"value":1053.15,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2018 Employee Stock Purchase Plan."}],"balance_after":904,"source":{"system":"sec-edgar","filing":"0001387131-20-001792","document":"saenger-form5_123119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713120001792/saenger-form5_123119.xml","form_type":"5"}},{"id":3535196,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2019-05-08T12:00:52.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":28835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":28835,"derivative":{"exercise_price":2.56,"exercise_date":"2020-05-06","expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":28835},"source":{"system":"sec-edgar","filing":"0001387131-19-003426","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713119003426/ownership.xml","form_type":"4"}},{"id":3535195,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2019-05-08T12:00:52.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":28835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":28835,"derivative":{"exercise_price":2.05,"exercise_date":"2020-05-06","expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":28835},"source":{"system":"sec-edgar","filing":"0001387131-19-003426","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713119003426/ownership.xml","form_type":"4"}},{"id":3629112,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2019-02-27T22:39:51.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":5170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":5170,"derivative":{"exercise_price":2.36,"exercise_date":"2020-02-26","expiration_date":"2029-02-25","underlying":"Common Stock","underlying_shares":5170},"source":{"system":"sec-edgar","filing":"0001387131-19-001537","document":"form4-saenger_022619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713119001537/form4-saenger_022619.xml","form_type":"4"}},{"id":3629111,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2019-02-27T22:39:51.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":5170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":5170,"derivative":{"exercise_price":1.89,"exercise_date":"2020-02-26","expiration_date":"2029-02-25","underlying":"Common Stock","underlying_shares":5170},"source":{"system":"sec-edgar","filing":"0001387131-19-001537","document":"form4-saenger_022619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000138713119001537/form4-saenger_022619.xml","form_type":"4"}},{"id":3893999,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2018-06-14T20:05:43.000Z","date":"2018-06-14","kind":"purchase","acquired":true,"shares":300,"price":4.1,"value":1230.0,"ownership":{"direct":true},"balance_after":3079,"source":{"system":"sec-edgar","filing":"0001615774-18-005289","document":"s110839_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000161577418005289/s110839_form4.xml","form_type":"4"}},{"id":4055136,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2018-02-15T21:08:32.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":39150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":39150,"derivative":{"exercise_price":4.25,"exercise_date":"2019-02-13","expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":39150},"source":{"system":"sec-edgar","filing":"0001615774-18-001262","document":"s109083_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000161577418001262/s109083_form4.xml","form_type":"4"}},{"id":4055135,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2018-02-15T21:08:32.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":39150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":39150,"derivative":{"exercise_price":3.4,"exercise_date":"2019-02-13","expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":39150},"source":{"system":"sec-edgar","filing":"0001615774-18-001262","document":"s109083_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000161577418001262/s109083_form4.xml","form_type":"4"}},{"id":4414268,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2017-03-02T02:22:25.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2016 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests 50% if the Issuer achieves enrollment of 250 patients in its HONOR study by December 31, 2017, with the remaining 50% vesting 1% for each patient that is enrolled in the HONOR study by December 31, 2017 in excess of 250, subject to a one year minimum service period prior to vesting."}],"balance_after":47500,"derivative":{"exercise_price":0.55,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0001615774-17-000858","document":"s105458_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000161577417000858/s105458_form4.xml","form_type":"4"}},{"id":4414267,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2017-03-02T02:22:25.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2016 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":47500,"derivative":{"exercise_price":0.55,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0001615774-17-000858","document":"s105458_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000161577417000858/s105458_form4.xml","form_type":"4"}},{"id":4454015,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-13T11:08:17.000Z","date":"2016-06-30","kind":"other","acquired":true,"shares":3296,"price":1.74,"value":5735.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. Employee Stock Purchase Plan."}],"balance_after":9335,"source":{"system":"sec-edgar","filing":"0001615774-17-000515","document":"s105311_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000161577417000515/s105311_form5.xml","form_type":"5"}}]}